Replies to post #553 on Claritus Pharmaceuticals Inc. (CLAZF)

[TheShadow]

SAN FRANCISCO and TEL AVIV, Israel, Sept. 13, 2018 (GLOBE NEWSWIRE) -- At the request of IIROC, Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") wishes to confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity.

https://finance.yahoo.com/news/kalytera-confirms-no-material-change-191140729.html

The IIROC is the Investment Industry Regulatory Organization of Canada.